LRCX · Lam Research Corporation

Current Thesis

Lam Research’s artificial-intelligence memory-equipment story still requires revenue confirmation, but its published recovery thesis has failed the weekly price test. The adjusted market series closed at $288.11 on Friday, 2026-09-18, below the $301 invalidation condition retained in the 2026-09-11 dossier. This resolves the uncertainty in that note, which had only a Thursday close below the boundary.

The operating question remains separate: Lam guided September-quarter revenue to $8.10 billion, plus or minus $400 million, on 2026-07-29. Meeting that midpoint would support conversion of equipment demand into revenue; it would not erase the completed price invalidation. Lam quarterly results

For the recovery leg covered here, the narrative is dead — the 2026-09-18 weekly close broke its published condition. This describes the failed market structure, not a demonstrated collapse in equipment demand. A subsequent weekly close above the previously published $319 recovery threshold, accompanied by September revenue meeting July’s midpoint, would support a new recovery assessment.

Bullish and bearish views on Lam Research Corporation

The model's bull view on Lam Research Corporation (LRCX), in brief: Reported demand has an operating foundation. The bear view: The weekly condition has failed. The 2026-09-18 adjusted close of $288.11 is below the $301 boundary in the 2026-09-11 published body. The recovery case is invalidated by that observation; a lower replacement threshold would change the original test. The broader decline remains… Both cases follow in full.

Bull Case

• Reported demand has an operating foundation. Lam reported June-quarter revenue of $6.72 billion on 2026-07-29. That result supports the equipment-demand premise, while September revenue remains the next company-specific conversion test. Lam quarterly results
• Management described pressure for earlier deliveries. Investing.com’s account of the 2026-09-10 Goldman Sachs conference reported customers requesting equipment sooner than Lam could deliver it. The inference that this supports the September conversion case fails if revenue misses the July guidance midpoint. Conference report
• Analyst expectations are not uniformly falling. MarketScreener reported that Berenberg raised its Lam price target to $420 from $350 on 2026-09-09. This documents an analyst’s revised expectation; it does not establish that the market has recovered. Analyst revisions

Bear Case

• The weekly condition has failed. The 2026-09-18 adjusted close of $288.11 is below the $301 boundary in the 2026-09-11 published body. The recovery case is invalidated by that observation; a lower replacement threshold would change the original test.
• The broader decline remains substantial. The adjusted market series records a three-month price decline of 29.7% and a distance of 33.5% below the 52-week high as of 2026-09-18. Those measurements establish price deterioration, without identifying its cause.
• Delivery pressure leaves conversion unresolved. The 2026-09-10 conference account described staffing and supply-chain execution demands. September revenue below the midpoint issued on 2026-07-29 would contradict this dossier’s conversion premise, although a midpoint miss alone would not establish a miss of the entire guidance range. Conference report

Setup & Price Structure

The relevant market levels remain the $301 invalidation boundary and $319 recovery threshold published in the 2026-09-11 body. The 2026-09-18 reference close of $288.11 is below both. Neither level is presented as a newly measured moving average or a fresh support estimate.

Coverage continued during the deterioration. Benzinga published competing artificial-intelligence slowdown and spending narratives on 2026-09-14, followed by semiconductor-fund and Lam-specific coverage on 2026-09-18. These observations establish clustered coverage; the sample is too small to support a claim about retail crowding, ownership concentration or the direction of fund flows.

Catalyst Calendar (next 30 days)

• 2026-09-30 — Micron fiscal fourth-quarter results. Micron confirmed the call on 2026-08-26. Its capital-spending commentary provides a dated test of the memory-investment premise: disclosed equipment-spending reductions or installation delays would weaken that premise. Micron’s results cannot establish Lam’s own revenue conversion. Micron announcement
• ~2026-10-21, estimated — Lam September-quarter results. This later event sits outside the next 30 days but directly tests the operating thesis. Investing.com lists this date; company confirmation remains unavailable. Revenue below the $8.10 billion midpoint issued on 2026-07-29 would fail the stated conversion test. Earnings calendar

What Would Change Our Mind

The loss of the published recovery boundary has already changed the assessment: a weekly close below $301 occurred with the $288.11 close on 2026-09-18. A later rebound cannot reverse that historical outcome.

A new recovery case would require a weekly close above the $319 threshold retained in the 2026-09-11 note and September-quarter revenue at least matching July’s guidance midpoint. Until both observations exist, neither management’s 2026-09-10 demand commentary nor Berenberg’s 2026-09-09 target increase supplies the missing confirmation.

Correlation Notes

The Semi foundry & equipment group assessment moved from maturing on 2026-08-30 to saturated on 2026-09-06 and remained saturated through 2026-09-20. The tracked group includes UMC, TSM and ONTO alongside Lam. This is a dated thematic classification, not a measured return correlation or evidence that the companies share identical demand exposures.

The 2026-09-18 Lam price breach establishes the single-name failure independently of that classification. Peer return histories and fund-flow measurements are unavailable here, so the evidence does not establish whether group effects or company-specific factors dominated the decline.